Melphalan has been approved in the United States and in the European Union and in the Other Countries

Studies listed may include approved and non-approved uses, formulations or treatment regimens. Before prescribing any product mentioned in this Register, healthcare Professionals should consult prescribing information approved in their country (view UK and US information for Healthcare Professionals).

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.

Melphalan studies

Select the study ID number to view the trial summary

Study ID	Phase	Title
ALKF1001	I	Report of a Biocomparability Study of Alkeran (melphalan) in Patients with Multiple Myeloma, Ovarian Cancer, Breast Cancer or other solid tumors for which Alkeran has activity.